Epithalon Biomarkers — Tracking Telomere & Aging Response
Epithalon biomarkers track telomere length, melatonin, cortisol, and oxidative stress markers to measure cellular aging response and peptide efficacy.
Category: Blog
Your blog category
Epithalon Animal vs Human Research — Key Differences
Epithalon animal studies show 30–40% lifespan extension, but human research remains limited to small-scale trials with no longevity endpoints — here’s
Epithalon Gene Expression — How This Peptide Works
Epithalon activates telomerase and regulates over 70 genes tied to aging, circadian rhythm, and cellular repair — here’s the mechanism behind the research.
Epithalon Bioavailability — Absorption & Delivery Routes
Epithalon bioavailability reaches 40–60% via subcutaneous injection but drops below 5% orally. Route selection determines therapeutic potential for
FOXO4-DRI Receptor Pharmacology — Senolytic Mechanism
FOXO4-DRI disrupts p53-FOXO4 protein binding in senescent cells, triggering apoptosis without affecting healthy tissue. Here’s the molecular mechanism
FOXO4-DRI p53 Pathway Mechanism — Cellular Senescence
FOXO4-DRI disrupts the FOXO4-p53 protein complex in senescent cells, restoring p53’s apoptotic function and triggering selective cell death without
FOXO4-DRI Signaling Pathway — Mechanism & Research Insights
FOXO4-DRI disrupts the FOXO4-p53 protein interaction, selectively targeting senescent cells while preserving healthy tissue — a breakthrough in aging
FOXO4-DRI Pharmacokinetics — Absorption & Half-Life Data
FOXO4-DRI exhibits a half-life of approximately 4–6 hours with subcutaneous bioavailability exceeding 85% — understanding these pharmacokinetic parameters
Epithalon Metabolism Research — Peptide Pathway Studies
Epithalon metabolism research reveals a five-day half-life and hepatic processing through cytochrome P450 enzymes, with peak bioavailability at 30 minutes
FOXO4-DRI Downstream Effects — Cellular Senescence Impact
FOXO4-DRI downstream effects trigger selective senescent cell apoptosis while preserving healthy cells — mediated through p53 nuclear exclusion and
